Long-term therapy of patients with stage I-II essential hypertension with moxonidine (based on results of clinical testing)

Authors
Olbinskaya, LI Morozova, TE Bobchenkov, YV
Citation
Li. Olbinskaya et al., Long-term therapy of patients with stage I-II essential hypertension with moxonidine (based on results of clinical testing), KARDIOLOGIY, 39(5), 1999, pp. 17-19
Citations number
6
Categorie Soggetti
Cardiovascular & Respiratory Systems
Journal title
KARDIOLOGIYA
ISSN journal
00229040 → ACNP
Volume
39
Issue
5
Year of publication
1999
Pages
17 - 19
Database
ISI
SICI code
0022-9040(1999)39:5<17:LTOPWS>2.0.ZU;2-N
Abstract
Clinical efficacy and tolerability of long term therapy with an imidazoline receptor agonist moxonidine were studied in 30 patients with stage I-II hy pertensive disease (essential hypertension). Moxonidine (0,2-0,6 mg/day) wa s found to be well tolerated moderately active hypotensive drug with positi ve effects on carbohydrate and lipid metabolism.